Braiteh, F., Patel, M. B., Parisi, M., Ni, Q., Park, S., & Faria, C. (2017). Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting. Cancer Manag Res.

Braiteh, Fadi, Manish B. Patel, Monika Parisi, Quanhong Ni, Siyeon Park, e Claudio Faria. "Comparative Effectiveness and Resource Utilization of Nab-paclitaxel Plus Gemcitabine Vs FOLFIRINOX or Gemcitabine for the First-line Treatment of Metastatic Pancreatic Adenocarcinoma in a US Community Setting." Cancer Manag Res 2017.

Braiteh, Fadi, et al. "Comparative Effectiveness and Resource Utilization of Nab-paclitaxel Plus Gemcitabine Vs FOLFIRINOX or Gemcitabine for the First-line Treatment of Metastatic Pancreatic Adenocarcinoma in a US Community Setting." Cancer Manag Res 2017.